T. Rowe Price Associates’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.32M | Sell |
352,868
-424,305
| -55% | -$8.8M | ﹤0.01% | 1184 |
|
|
2025
Q1 | $13.5M | Sell |
777,173
-617,133
| -44% | -$10.7M | ﹤0.01% | 1050 |
|
|
2024
Q4 | $37.8M | Sell |
1,394,306
-690,381
| -33% | -$18.7M | ﹤0.01% | 831 |
|
|
2024
Q3 | $91.5M | Sell |
2,084,687
-228,834
| -10% | -$10M | 0.01% | 589 |
|
|
2024
Q2 | $90.9M | Buy |
2,313,521
+752,571
| +48% | +$29.6M | 0.01% | 565 |
|
|
2024
Q1 | $66.9M | Sell |
1,560,950
-118,486
| -7% | -$5.08M | 0.01% | 645 |
|
|
2023
Q4 | $68.5M | Sell |
1,679,436
-834,127
| -33% | -$34M | 0.01% | 616 |
|
|
2023
Q3 | $127M | Buy |
2,513,563
+740,213
| +42% | +$37.3M | 0.02% | 468 |
|
|
2023
Q2 | $73.7M | Buy |
1,773,350
+986,845
| +125% | +$41M | 0.01% | 594 |
|
|
2023
Q1 | $18.7M | Buy |
+786,505
| New | +$18.7M | ﹤0.01% | 935 |
|